Addressing challenges of reprocessing and reducing HAIs at MD&M East in NYC
May reduce unnecessary biopsies
Focusing on one of four ways in which artificial intelligence is disrupting medicine
Research from Australia presented at SNMMI
Prescient Imaging aims to bring molecular imaging to the patient
How PET and SPECT are reinventing the way we evaluate and image the brain
Can [F-18] MK-6240 stage neuro-degenerative disease and assess treatment?
Swedish researchers take lifesaving cardiac devices to the sky
Showcasing lower doses, faster scan times and higher sensitivity
Assessing amyloid pathology and neuronal injury in a single session
Findings may have practice-changing implications
Unique market forces influence the utilization of different tracers
Scans up to 30 percent faster than previous generations
High demand for mechanical valves
Ninety percent of the clot can be dissolved in four hours
Machine learning is changing radiology
Canadian researchers share findings at SNMMI
Seeking common ground in what's been a polarizing debate
Could 'drive a paradigm shift' in the early diagnosis of deadly coronary artery disease
Checking in with advancements in PET and SPECT
New machines, material and services on the way
How oncologists are seeking ways to provide affordable and effective care
Promising Lutathera research highlighted at SNMMI meeting
Aims to increase research and development
Equipped with a series of improved features
Analysts take a deep dive into ROI
Helping biomeds track down critical mobile assets in real time
Get to know what's in store with 2018 Medicare Fee Schedule Proposed Rules
Analyst calls timing unsurprising in light of unsatisfactory stock performance
Bringing flexibility to molecular imaging investments
'ICE will become the standard way of doing it over the next couple of years'
Combining therapy and diagnosis with radiopharmaceuticals
New NEJM report sparks opposing views in screening debate
Renewed optimism over molecular imaging's potential at plenary session
The year's biggest event for nuclear medicine and molecular imaging
Researchers say it shows promise in preclinical test
Floors are an under-appreciated source of pathogen dissemination
Meeting the growing demand for multi-modality imaging
ALARA objectives deemed 'misguided,' 'detrimental'
Basing treatment decisions on genomics